Allogene Therapeutics (ALLO) Projected to Post Quarterly Earnings on Monday
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Monday, May 12th. Analysts expect Allogene Therapeutics to post earnings of ($0.28) per share and revenue of $0.00 million for the quarter. Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) last issued its quarterly earnings […]
